Healthcare provider profile · identity verified

Mandy Cranney, NP

Nurse Practitioner · WALDOBORO, ME · NPI 1104443803

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	536	161
Lisinopril	Lisinopril	454	121
Metformin Hcl	Metformin Hcl	165	51
Tamsulosin Hcl	Tamsulosin Hcl	154	42
Gabapentin	Gabapentin	145	39
Losartan Potassium	Losartan Potassium	145	42
Albuterol Sulfate Hfa	Albuterol Sulfate	141	58
Omeprazole	Omeprazole	140	42
Hydrochlorothiazide	Hydrochlorothiazide	137	41
Amlodipine Besylate	Amlodipine Besylate	133	44
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	126	32
Duloxetine Hcl	Duloxetine Hcl	123	32
Metoprolol Tartrate	Metoprolol Tartrate	111	32
Glipizide Er	Glipizide	108	24
Metoprolol Succinate	Metoprolol Succinate	102	31
Levothyroxine Sodium	Levothyroxine Sodium	99	35
Pantoprazole Sodium	Pantoprazole Sodium	95	33
Alprazolam	Alprazolam	87	12
Metformin Hcl Er	Metformin Hcl	83	23
Venlafaxine Hcl Er	Venlafaxine Hcl	78	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	77	11
Rosuvastatin Calcium	Rosuvastatin Calcium	77	26
Oxycodone Hcl	Oxycodone Hcl	76	11
Sertraline Hcl	Sertraline Hcl	76	23
Pravastatin Sodium	Pravastatin Sodium	75	21
Ozempic	Semaglutide	73	22
Ezetimibe	Ezetimibe	71	19
Atenolol	Atenolol	70	26
Clopidogrel	Clopidogrel Bisulfate	68	18
Furosemide	Furosemide	65	35
Glipizide	Glipizide	57	17
Allopurinol	Allopurinol	55	21
Clonazepam	Clonazepam	55	suppressed
Paroxetine Hcl	Paroxetine Hcl	54	suppressed
Eliquis	Apixaban	51	14
Famotidine	Famotidine	50	11
Simvastatin	Simvastatin	50	18
Fluoxetine Hcl	Fluoxetine Hcl	48	16
Januvia	Sitagliptin Phosphate	45	suppressed
Prednisone	Prednisone	44	29
Tramadol Hcl	Tramadol Hcl	44	13
Trazodone Hcl	Trazodone Hcl	43	13
Chlorthalidone	Chlorthalidone	40	14
Finasteride	Finasteride	40	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	38	35
Methadone Hcl	Methadone Hcl	37	suppressed
Ondansetron Odt	Ondansetron	37	suppressed
Lorazepam	Lorazepam	36	18
Potassium Chloride	Potassium Chloride	36	11
Bumetanide	Bumetanide	33	suppressed
Montelukast Sodium	Montelukast Sodium	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	12
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	29	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	28	suppressed
Diazepam	Diazepam	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	26
Lovastatin	Lovastatin	28	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	17
Azithromycin	Azithromycin	27	24
Colchicine	Colchicine	27	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	11
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Morphine Sulfate Er	Morphine Sulfate	23	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Torsemide	Torsemide	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Nitroglycerin	Nitroglycerin	21	16
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Carisoprodol	Carisoprodol	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Cilostazol	Cilostazol	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	18	13
Fluconazole	Fluconazole	17	14
Meclizine Hcl	Meclizine Hcl	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Benicar	Olmesartan Medoxomil	16	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Jardiance	Empagliflozin	16	suppressed
Meloxicam	Meloxicam	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Carvedilol	Carvedilol	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Dupixent Syringe	Dupilumab	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Serevent Diskus	Salmeterol Xinafoate	14	suppressed
Baclofen	Baclofen	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	13	12
Klor-Con M10	Potassium Chloride	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Penicillin V Potassium	Penicillin V Potassium	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Veltassa	Patiromer Calcium Sorbitex	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error